We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The Efficacy and Safety of Laser and Electrosurgical Transurethral Procedures for the Treatment of BPO in High-Risk Patients: A Systematic Review.
- Authors
Burtt, Glyn; Springate, Cassandra; Martin, Alison; Woodward, Emily; Zantek, Paul; Jaafari, Feras Al; Muir, Gordon; Misrai, Vincent
- Abstract
Keywords: benign prostatic hyperplasia; high-risk; GreenLight; Holmium laser enucleation of the prostate; HoLEP; Laser; transurethral resection of the prostate; TURP EN benign prostatic hyperplasia high-risk GreenLight Holmium laser enucleation of the prostate HoLEP Laser transurethral resection of the prostate TURP 247 257 11 09/19/22 20220601 NES 220601 Introduction GreenLight, Holmium and Thulium lasers are supported with evidence to treat benign prostatic obstruction (BPO) and are routinely used for vapourisation, vaporesection or anatomical enucleation of the prostate. The maximum reported proportion of patients with clot retention was also lower with GreenLight than the other interventions (Figure 2), although again all interventions included studies where no patients developed this complication. Discussion There are ethical concerns in randomising high-risk patients between different surgical treatments for BPO.[14] This is due to concerns about exposing high-risk patients to TURP, which would be an obvious comparator in any randomised controlled trial. In patients with urinary retention, none of those treated with Greenlight or mTURP required transfusion, compared with 2.78% of patients after HoLEP and 1.7% after Thulium laser.
- Subjects
RETENTION of urine; TRANSURETHRAL prostatectomy; BLADDER obstruction; BENIGN prostatic hyperplasia; LASERS
- Publication
Research & Reports in Urology, 2022, Vol 14, p247
- ISSN
2253-2447
- Publication type
Article
- DOI
10.2147/RRU.S361956